Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $49,988 |
Sells | 6 | $30,262 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 May 2024 16:13 | LENZ | LENZ Therapeutics Inc | CHEVALLARD DANIEL R. | Chief Financial Officer | 14 May 2024 | Purchase | 3,188 | 15.68 | 49,988 | D |
27 Feb 2024 19:54 | VIRX | Viracta Therapeutics Inc | CHEVALLARD DANIEL R. | CFO and COO | 27 Feb 2024 | Sale | 3,405 | 0.7322 | 2,493 | D |
28 Nov 2023 19:06 | VIRX | Viracta Therapeutics Inc | CHEVALLARD DANIEL R. | CFO and COO | 28 Nov 2023 | Sale | 3,720 | 0.5 | 1,860 | D |
29 Aug 2023 18:47 | VIRX | Viracta Therapeutics Inc | CHEVALLARD DANIEL R. | CFO and COO | 28 Aug 2023 | Sale | 3,512 | 1.45 | 5,092 | D |
26 May 2023 19:29 | VIRX | Viracta Therapeutics Inc | CHEVALLARD DANIEL R. | CFO and COO | 25 May 2023 | Sale | 3,635 | 1.4196 | 5,160 | D |
28 Feb 2023 18:22 | VIRX | Viracta Therapeutics Inc | CHEVALLARD DANIEL R. | CFO and COO | 27 Feb 2023 | Sale | 3,599 | 1.6812 | 6,051 | D |
29 Nov 2022 17:33 | VIRX | Viracta Therapeutics Inc | CHEVALLARD DANIEL R. | CFO and COO | 28 Nov 2022 | Sale | 3,532 | 2.7196 | 9,606 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)